Fundacion Octaedro, El Zurriago E8-28, Quito, Ecuador.
Institute for Global Health & Translational Sciences, State University of New York Upstate Medical University, Syracuse, New York, USA.
BMC Public Health. 2021 Apr 1;21(1):637. doi: 10.1186/s12889-021-10715-x.
Testing is crucial for COVID-19 response and management, however, WHO's preparedness index omits estimations of actual testing capabilities, which influence the ability to contain, mitigate and clinically manage infectious diseases. With one of the highest excess death rates globally, Ecuador had a comparatively low number of confirmed COVID-19 cases, which may have been influenced by limited availability of data for decision-making due to low laboratory capacity.
We examine de-identified data on 55,063 individuals with suspected COVID-19 between February 27 and April 30, 2020 included in the RT-PCR testing database collected by the Ministry of Health. Processing times and rates per province, and the number of pending tests, were tallied cumulatively. We assessed the relationship between sample shipping, laboratory capacity and case completion using a negative binomial generalized linear model.
The national average time for case completion was 3 days; 12.1% of samples took ≥10 days to complete; the national average daily backlog was 29.1 tests per 100,000 people. Only 8 out of 24 provinces had authorized COVID-19 processing laboratories but not all processed samples. There was an association between samples coming from outside the processing laboratory province, the number of other samples present at the laboratory during processing, and the amount of time needed to process a sample. Samples from another province took 1.29 times as long to process, on average. The percentage of pending results on April 30 was 67.1%.
A centralized RT-PCR testing system contributes to critical delays in processing, which may mask a case burden higher than reported, impeding timely awareness, and adequate clinical care and vaccination strategies and subsequent monitoring. Although Ecuador adapted or authorized existing facilities to address limitations in laboratory capacity for COVID-19, this study highlights the need to estimate and augment laboratory capabilities for improved decision making and policies on diagnostic guidelines and availability. Support is needed to procure the necessary human and physical resources at all phases of diagnostic testing, including transportation of samples and supplies, and information management. Strengthening emergency preparedness enables a clear understanding of COVID-19 disparities within and across the country.
检测对于新冠疫情应对和管理至关重要,然而,世界卫生组织的准备指数忽略了对实际检测能力的估计,而这些能力会影响传染病的控制、缓解和临床管理能力。厄瓜多尔的全球超额死亡率位居前列,但确诊的新冠病例数量相对较少,这可能是由于实验室能力有限,导致决策数据有限。
我们检查了 2020 年 2 月 27 日至 4 月 30 日期间卫生部收集的 RT-PCR 检测数据库中 55063 名疑似新冠患者的匿名数据。按省份累计计算处理时间和速度,以及待处理检测数量。我们使用负二项广义线性模型评估了样本运输、实验室能力和病例完成之间的关系。
全国平均完成病例的时间为 3 天;12.1%的样本需要≥10 天才能完成;全国平均每天积压 29.1 个检测样本。24 个省份中只有 8 个拥有授权的新冠处理实验室,但并非所有实验室都处理了样本。来自处理实验室所在省份之外的样本、处理期间实验室中的其他样本数量,以及处理样本所需的时间之间存在关联。来自其他省份的样本处理时间平均延长了 1.29 倍。截至 4 月 30 日,待处理结果的比例为 67.1%。
集中式 RT-PCR 检测系统导致处理过程中的严重延迟,这可能掩盖了比报告更高的病例负担,阻碍了及时的认识,以及充分的临床护理和疫苗接种策略以及随后的监测。尽管厄瓜多尔为解决新冠病毒检测实验室能力的限制而调整或授权了现有设施,但本研究强调需要估计和增加实验室能力,以改善诊断指南和供应的决策和政策。需要提供支持,以在诊断检测的所有阶段获得必要的人力和物力资源,包括样本和用品的运输以及信息管理。加强应急准备能力可以更清楚地了解国内外新冠疫情的差异。